Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Board/Management Information 2020

Sep 14, 2020

62142_rns_2020-09-14_289d5c4c-ee1d-4997-99a2-9d9ceadfa635.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

·t· Marksans Pharma Ltd.

National Stock Exchange of India Limited

Exchange Plaza C-l1 Block IG/Bandra Kurla Complex1 Bandra (EL Mumbai - 400051. Scrip Code: MARKSANS

BSELimited

Phiroze Jeejeebhoy Towers Dalal Street l FortI Mumbai - 400001. Scrip Code: 524404

14[th] Septembe-r, 2020

This is with reference to the Companis letter dated 3[rd] Septemberl 2020 regarding appointment of Dr. Meena Rani Surana as an independent woman director of the Company.

It has come to our notice a typographical error in the above letter. We hereby write to correct the said typographical error.

Please be informed that appointment of Dr. Meena Rani Surana is effective from 4[th] Septemberl 2020 (instead of 3[rd] Septemberl 2020).

Yours For M faithfullYI mns ~ited

- ~ 0U!MJ Harshavardhan Panigrahi Company Secretary

Marksans Pharma Ltd.

.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Exten~ion Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: [email protected] www.marksanspharma.com